Atripla Related Published Studies
Well-designed clinical trials related to Atripla (Efavirenz / Emtricitabine / Tenofovir)
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. [2011.03.27]
Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. [2010.02]
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. [2009.06.01]
Other research related to Atripla (Efavirenz / Emtricitabine / Tenofovir)
Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla(R)): a review of its use in the management of HIV infection. [2010.12.03]
Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects
after switching to a simplified, single-tablet regimen of efavirenz,
emtricitabine, and tenofovir DF. [2010]
Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. [2007.10.01]
Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen. [2007.07.19]
Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? [2007.02]
Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. [2006]
Other possibly related research studies
[Treatment of HIV infection in 2006: highlights] [2007.01.10]
Anti-HIV drugs. [2007]
The first once-daily single-tablet regimen for the treatment of HIV-infected patients. [2007.07]
Efficacy and safety of once-daily regimens in the treatment of HIV infection. [2008]
[Current role of tenofovir in clinical medicine] [2008.06]
Disseminated bartonellosis presenting as neuroretinitis in a young adult with human immunodeficiency virus infection. [2010.07]
Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007. [2009.09]
Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007. [2009.09]
A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States. [2011.09]
Factors associated with complete adherence to HIV combination antiretroviral therapy. [2011.03]
|
